eClinical

Technology platforms are today continually being adapted into the clinical trial life cycle with the promise of efficiency and reduced risk. CRF Health believes its combined eCOA/eConsent solution could improve the flow of documentation between investigators and sponsors.

The need to move beyond a point-solutions approach to one built around applications designed to manage the end-to-end clinical trial process is crucial.

Successful project management requires efficiency in both identifying and addressing bottlenecks before they impact study timelines. This article examines how to design data collection criteria for optimal performance.

Today’s convergence of health data and technology is fun to watch unfold, but a focused vision on system and process integration-and the framework for continuous enrichment-will be key to future lasting gains for clinical research.

Using eClinical technologies to access vendor performance allows for researchers to choose appropriate vendors based on trial design, needs and risks. These decisions can be made using historical comparative data from a normative database.

Worldwide Clinical Trials recently announced the results of a survey that evaluated the perceptions of clinical trial site investigators who use electronic clinical outcome assessment (eCOA) technologies.

The data analysis in this article will delve into Clinical SCORE’s normative database to generate predictive models, and qualitatively reason the findings.

Exploring three pivotal technology areas that could reshape global studies over the next 10 years.

This article explores the survey data to uncover opinions about traditional endpoint adjudication use (i.e., Excel, paper, emails, etc.) compared eClinical technologies to adjudicate events.

The Site Impact Survey was designed by Clinical Ink to evaluate clinical research coordinator and investigator experiences with Clinical Ink’s eSource system compared to paper source.

In our latest webcast that aired live October 14, Oracle Health Sciences brought together three presenters from smaller or medium-size organizations in an effort to educate similar-sized companies on the benefits of EDC.

Even with the rapid increase in clinical trials and demand for cloud-based systems, doing business in China is not easy if you are unfamiliar with the territory.

Survey provides new benchmarks on e-solutions adoption, but actual impact data remains elusive.

How to satisfy regulatory concerns about EDC data integrity and site controls over its source records.

In clinical trials, the ability to effectively plan, collect and maintain essential clinical trial documentation is challenging.

 Last month, Veeva Systems unveiled the results of its 2015 Paperless TMF Survey: Annual Report. The survey is in its second year, and as Jennifer Goldsmith, vice president of Veeva Vault, told Applied Clinical Trials, it was interesting and significant to report on the year-over-year results.

Understanding the roles of eTMF, CTMS, and study startup solutions in the clinical trials process

eSource is not a new term. But eSource does seem to be getting a lot of attention lately.

Historically, some longstanding challenges have hindered efforts to integrate patient data from EMRs (Electronic Medical Record systems) with EDC (Electronic Data Capture) systems.

ERT’s announcement of its intention to acquire PHT makes more than sense. And when speaking with the companies’ CEOs, Jim Corrigan and Philip Lee respectively, the potential for success is greater than any challenges the current clinical trials market could throw their way.

Combing for clinical trials patients and the best way to make the match between trial and patient is a multifaceted task.

As we move towards cloud-based technologies, lingering questions and concerns remain.

Take a look at past, present, and future clinical study processes and see how IRT/EDC unification increases study agility and efficiency while decreasing cost to sponsors.

Does the emerging world still lag behind in EDC adoption?

Overcoming clinical research inefficiencies to improve trial outcomes.

Efficiency and ease of use-bringing technologies together into a converged suite.

Using interactive response technology to avoid unblinding in randomized controlled trials.

Medidata

Medidata